Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production
Article first published online: 17 JUL 2009
© 2009 British Society for Immunology
Clinical & Experimental Immunology
Volume 158, Issue 1, pages 99–105, October 2009
How to Cite
Heidt, S., Roelen, D. L., Eijsink, C., Eikmans, M., Claas, F. H. J. and Mulder, A. (2009), Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production. Clinical & Experimental Immunology, 158: 99–105. doi: 10.1111/j.1365-2249.2009.03996.x
- Issue published online: 2 SEP 2009
- Article first published online: 17 JUL 2009
- Accepted for publication 7 July 2009
- 1The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991; 325:110–17., .
- 2Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002; 2:758–60., , et al.
- 3Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 2003; 76:631–6., , et al.
- 4Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008; 359:242–51., , et al.
- 5Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 2003; 75:1490–5., , et al.
- 6Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant 2005; 9:408–15., , , , .
- 7Fc gamma RIIB as a potential molecular target for intravenous gamma globulin therapy. J Allergy Clin Immunol 2001; 108:S95–8., , .
- 8IVIG and HLA antibodies. Evidence for inhibition of complement activation but not for anti-idiotypic activity. Am J Transplant 2005; 5:2786–90., .
- 9Modulation of mononuclear phagocyte function by intravenous gamma-globulin. J Immunol 1984; 132:745–50., , , , .
- 10Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor. Thromb Haemost 2002; 88:898–9., .
- 11Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT). Hum Immunol 1997; 56:106–13., , , , .
- 12Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin. Transplantation 2008; 86:1292–300., , , , , .
- 13Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. J Clin Immunol 1992; 12:325–34., , , .
- 14Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro. Scand J Immunol 1993; 38:477–84., , , , .
- 15A-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients. Transplantation 1993; 56:335–7., , et al.
- 16Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994; 57:553–62., , , , .
- 17Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use. J Immunol 1986; 136:4407–13..
- 18Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol 1985; 62:200–7..
- 19Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin. J Clin Immunol 1991; 11:152–8., , et al.
- 20The suppressive effect of gammaglobulin preparations on in vitro pokeweed mitogen-induced immunoglobulin production. Clin Exp Immunol 1986; 65:409–15., , .
- 21Contribution of stabilizing agents present in intravenous immunoglobulin preparations to modulation of mononuclear cell proliferation in vitro. Scand J Immunol 1996; 44:585–91., , .
- 22Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG. Blood 2003; 101:3065–73., , , , .
- 23The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system. J Immunol 1987; 138:795–801., , , , .
- 24Intravenous immunoglobulin inhibits IgE production in human B lymphocytes. J Allergy Clin Immunol 1998; 102:421–7., , et al.
- 25The effect of desensitization protocols on human splenic B-cell populations in vivo. Am J Transplant 2007; 7:402–7., , , , , .
- 26Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG. Am J Transplant 2008; 8:133–43., , et al.
- 27Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells. Blood 2007; 110:3253–62., , et al.
- 28Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin. Clin Immunol Immunopathol 1994; 73:180–6., , , , .
- 29Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 1989; 143:4104–9., .
- 30Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest 1990; 85:620–5., .
- 31F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 2003; 9:431–8., , et al.